Pembrolizumab-Induced Toxic Epidermal Necrolysis

Immunotherapy has nowadays become part of the mainstay of treatment for several cancers. In this report, we present a case of toxic epidermal necrolysis (TEN) occurring as a relatively rare complication of pembrolizumab, which is a humanized monoclonal anti-programmed cell death-1 (anti-PD1) IgG4 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Borg, Luca, Buhagiar, Malcolm, La Ferla, Elisa, Pisani, David, Said, Janabel, Boffa, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941788/
https://www.ncbi.nlm.nih.gov/pubmed/36825108
http://dx.doi.org/10.1159/000526931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941788/
https://www.ncbi.nlm.nih.gov/pubmed/36825108
http://dx.doi.org/10.1159/000526931

Ejemplares similares